Printer Friendly

BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT

 BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT
 ST. PAUL, Minn., May 1 /PRNewswire/ -- Bioplasty, Inc.


(NASDAQ-NMS: BIOP) announced today that it has settled the lawsuit brought by McGhan Medical Corporation alleging Bioplasty's silicone gel- filled mammary implant shells infringed two of McGhan's U.S. patents relating to breast implants. Bioplasty has paid McGhan a $275,000 lump sum payment for all prior sales and for a non-exclusive license for future sales, if any, of silicone gel-filled breast implants. Bioplasty has previously announced that it has withdrawn from the domestic and foreign silicone gel-filled breast implant markets.
 Bioplasty, Inc. has more the 20 years experience in the development, manufacturing and marketing of plastic surgery products worldwide. Bioplasty's stock is currently traded on NASDAQ National Market System under the symbol "BIOP."
 -0- 5/1/92
 /CONTACT: Timothy P. Lawin or Donald A. Major, 612-636-4112, both of Bioplasty/
 (BIOP) CO: Bioplasty, Inc. ST: Minnesota IN: MTC SU:


AL -- MN016 -- 5690 05/01/92 18:00 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 1, 1992
Words:161
Previous Article:WASHINGTON STATE BOARD CANCELS HEARINGS ON SUSPENDED PHARMACIES' LICENSES
Next Article:BIOMIRA ANNOUNCES 1992 FIRST QUARTER FINANCIAL RESULTS


Related Articles
INAMED BRINGS PATENT INFRINGEMENT SUIT AGAINST BIOPLASTY
BIOPLASTY, INC., ANNOUNCES RECEIPT OF PATENT INFRINGEMENT COMPLAINT
BIOPLASTY RECEIVES BREAST IMPLANT PATENT
FDA CALLS FOR A UNITED STATES MORATORIUM ON SILICONE GEL-FILLED BREAST IMPLANTS
BIOPLASTY LICENSES SYNTHETIC WOUND CARE DRESSING
BIOPLASTY SUBMITS INVESTIGATIONAL DEVICE EXEMPTION (IDE) FOR ITS MISTI GOLD BREAST IMPLANTS
BIOPLASTY AGREES TO PROPOSED SETTLEMENT OF SHAREHOLDERS' SUIT
BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT
BIOPLASTY, INC. ANNOUNCES PROHIBITION OF SPIN OFF RECOMMENDED
BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters